European Manufacturer Entering the US

A mid-sized European device manufacturer with strong CE Mark credentials had repeatedly failed to crack the US market. They had trialed two US distributors, both selected through existing relationships. Launches stalled, regulatory expectations were misunderstood, and leadership viewed the US as “too hard and too expensive.”

Meanwhile, investors were pressuring management to access the US reimbursement upside and justify prior R&D and clinical investments. Each delay increased carrying costs, weakened the competitive position, and risked copycat technologies gaining FDA clearance first.

Distributor Principles stepped in as the client’s de facto US division. We rebuilt the market entry strategy from the ground up: structured US market and access feasibility, refined indications and value messaging for US payers and providers, and ran a rigorous distributor mapping and qualification process. We redesigned contracts to include clear performance targets, data sharing, and compliance obligations aligned with FDA expectations.

Within a defined timeline, the client secured a high-performing US partner, achieved a significantly shortened time-to-first-revenue, and established a compliant, scalable US footprint. metrics: time-to-launch reduced by 20%, first-year US revenues exceeding plan by 31%, and distributor productivity up 62% versus prior attempts.